- Conditions
- Respiratory Distress Syndrome in Premature Infant
- Interventions
- AeroFact, nCPAP
- Drug · Other
- Lead sponsor
- Aerogen Pharma Limited
- Industry
- Eligibility
- 26 Weeks to 31 Weeks
- Enrollment
- 261 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 37
- States / cities
- Little Rock, Arkansas • Berkeley, California • Orange, California + 27 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–4
of 4
matching trials from the live ClinicalTrials.gov search.
- Conditions
- COVID-19
- Interventions
- VentaProst (inhaled epoprostenol delivered via a dedicated delivery system)
- Drug
- Lead sponsor
- Aerogen Pharma Limited
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Respiratory Distress Syndrome, Pre-term Infants
- Interventions
- APC-0101 (SF-RI 1 surfactant for inhalation combined with a dedicated delivery system), Control
- Combination Product · Other
- Lead sponsor
- Aerogen Pharma Limited
- Industry
- Eligibility
- 1 Hour to 24 Hours
- Enrollment
- 520 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 12
- States / cities
- Little Rock, Arkansas • La Jolla, California • Jacksonville, Florida + 9 more
- Conditions
- Pulmonary Hypertension
- Interventions
- VentaProst
- Combination Product
- Lead sponsor
- Aerogen Pharma Limited
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 3
- States / cities
- Stanford, California • Chicago, Illinois • Boston, Massachusetts